Humana Inc. Files 8-K for Regulation FD Disclosure

TL;DR

Humana filed an 8-K for a Reg FD disclosure on Oct 2, 2025.

AI Summary

Humana Inc. filed an 8-K on October 2, 2025, reporting a Regulation FD Disclosure. The filing does not contain specific financial transactions or material events beyond this disclosure type.

Why It Matters

This filing indicates Humana Inc. is making a public disclosure under Regulation Fair Disclosure, ensuring all investors receive the same material information simultaneously.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not appear to contain information about significant financial events or changes in business operations.

Key Players & Entities

• Humana Inc. (company) — Registrant
• October 2, 2025 (date) — Date of earliest event reported
• Regulation FD (regulation) — Type of disclosure

FAQ

Key Financial Figures

• $13.77 — a affirms its guidance of approximately $13.77 in diluted earnings per common share ("
• $17.00 — common share ("EPS"), or approximately $17.00 in adjusted earnings per common share (

Filing Documents

• hum-20251002.htm (8-K) — 40KB
• 0000049071-25-000048.txt ( ) — 155KB
• hum-20251002.xsd (EX-101.SCH) — 2KB
• hum-20251002_lab.xml (EX-101.LAB) — 21KB
• hum-20251002_pre.xml (EX-101.PRE) — 12KB
• hum-20251002_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Supplementary Audio Commentary Supplementary audio commentary from Humana's President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. 2026 Medicare Advantage Star Ratings Based on preliminary 2026 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare and Medicaid Services (CMS), which was inadvertently accessible on CMS Plan Finder for a period of time on October 1, 2025, Humana Inc. ("the Company") has approximately 1.2 million, or 20%, of its members currently enrolled in plans rated 4 stars and above for 2026, with an average Star rating of 3.61, consistent with the Company's 2025 average MA Star Rating. The Company also has 14% of members in 4.5 star plans in 2026, up from 3% in 2025. Importantly, the Company's preliminary 2026 MA Star Ratings are generally in line with the assumptions utilized in its multiyear financial planning. As a result, there is no change to the 2025 to 2028 incremental earnings potential detail shared at the Company's 2025 Investor Conference on June 16, 2025. As a reminder, the Company had a short period of time to impact 2026 Star Ratings performance once the 2025 Star Ratings were released in the fall of 2024. While the Company is not satisfied with its 2026 Star Ratings, it is pleased with the tactical operational improvements made during the final months of the 2026 measurement period, creating a solid foundation for the Company's expected return to Top Quartile results for the 2027 Star Ratings. Finally, the Company is executing on a MA contract diversification strategy, beginning with the 2026 Annual Election Period beginning on October 15, 2025. As a result, the percent of members expected to be enrolled in contracts rated 4 stars and above in 2027 (the payment year impacted by 2026 MA Star Ratings) is meaningfully higher than the approximately 20% noted above, which is based on

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: October 2, 2025

View Full Filing

View this 8-K filing on SEC EDGAR